MHRA Surveillance for safety of medicines

 In MRHA News and Safety Alerts

The MHRA is responsible for licensing all medicines in the UK and continues to monitor for patient safety after a medicine has become available.

The main method for the MHRA to get reports of potential adverse reactions to medication is via the YellowCard scheme. This is a form which is found at the back of the BNF or can be completed online at

Another method involves carrying out research using patient records either in national databases or more specifically.

In order to support the work of the MHRA to monitor medication safety, Ashtons is planning to participate in patient-safety surveillance work in the future and we would propose to work with our hospitals to obtain the data. Before doing this, we would contact hospitals to discuss the issues and it would of course be necessary to obtain consent from patients.

Further information on surveillance reporting of side-effects will be provided to hospitals in the near future.


Photo by en:User:Sponge [GFDL ( or CC-BY-SA-3.0 (], via Wikimedia Commons

Recent Posts

Start typing and press Enter to search

dip testing kitsPills